📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A commercial vaccine based on PCV2a and an experimental vaccine based on a variant mPCV2b are both effective in protecting pigs against challenge with a 2013 U.S. variant mPCV2b strain. (2014)

First Author: Opriessnig T

Attributed to: Novel strategies to control virus infection and disease funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.vaccine.2013.11.010

PubMed Identifier: 24269319

Publication URI: http://europepmc.org/abstract/MED/24269319

Type: Journal Article/Review

Volume: 32

Parent Publication: Vaccine

Issue: 2

ISSN: 0264-410X